Women Who Receive False Positive Mammography Results Are Less Likely to Attend Follow-Up Screenings
September 4th 2024The authors stress that health care providers should explain false positive results to their patients, reassure them that results may be negative, and stress the significance of continued screenings.
Read More
FDA Grants Fast Track Designation for AC699 for Patients With ER+/HER2– Breast Cancer
August 15th 2024AC699 is being evaluated for patients with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2 negative (HER2–), estrogen receptor 1-mutated advanced or metastatic breast cancer with disease progression on or after at least 1 line of endocrine-based therapy.
Read More